IS OUR MISSION
Reasons why we do what we do and that lead us to our mission: Improve early breast cancer diagnosis
HIGH INCIDENCE OF BREAST CANCER
TECHNOLOGICAL LIMITATIONS
Metabolic information
Portable, no infrastructure required
High specificity
No specialized operator and autonomous
No ionizing radiation.
Suitable for all patients
No ionizing radiation
Pamela Pardini, PhD / CEO Nicolás Carbone, PhD / CTO
Alberto Rodriguez Navarro, MD Oren Gershtein Pamela Pardini, PhD / CEO
Pamela Munster, MD UCSF
Daniela Iriarte, Physicist, PhD
Demian Vera, Physicist, MSc
Héctor García, Physicist, PhD
Héctor Oscar Di Rocco, Physicist, PhD
Juan Pomarico, Physicist, PhD
L. Mariel Bernal, BioEng, MBA
M. Victoria Waks Serra, Physicist, PhD
Silvana Puca, MD, Medical Advisor
Foundation of Biomedical Optics Group
Optical mammography device idea
Prendete award
IB50k Award
Birth of Bionirs
CITES investment
First prototype
IP - national phases
First clinical trials
2nd prototype
2005
2011
2017
2018
2020
2021
2022
UNICEN Campus Universitario – Tandil, Buenos Aires, Argentina contacto@bionirs.com
No ionizing radiation.
. 
Alberto Rodriguez Navarro, MD
UNICEN Campus Universitario – Tandil, Buenos Aires, Argentina contacto@bionirs.com
UNICEN Campus Universitario – Tandil, Buenos Aires, Argentina contacto@bionirs.com
Follow us!
bionirs